{"title":"Galactosyl BODIPY-based nanoparticles as a type-I photosensitizer for HepG2 cell targeted photodynamic therapy","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA00041B","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA00041B\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,8735-8739<br /><b>DOI</b>: 10.1039/D4RA00041B, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Jin-Yu Liu, Ye Tian, Lei Dong<br />Herein, we report galactosyl diiodo-BODIPY-based nanoparticles as a type-I photosensitizer (PS) with high water solubility for HepG2 cell targeted photodynamic therapy.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"5d2e88f2ea4bb8a2adbea398f4588ac8df7f248c56f4647150f5eab0d66ccadd","category":"Environment"}